These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 203125)

  • 1. [The application of guanidine hydrochloride to the treatment of degenerative nervous and muscular diseases. II. Amino acid analysis of the CSF and serum: follow-up determinations (author's transl)].
    Gründig E; Gerstenbrand F; Maida E; Binder H; Hawrylewicz A
    Wien Klin Wochenschr; 1978 Jan; 90(2):48-56. PubMed ID: 203125
    [No Abstract]   [Full Text] [Related]  

  • 2. [The application of guanidine hydrochloride to the treatment of degenerative nervous and muscular diseases. I. Clinical results (author's transl)].
    Maida E; Gerstenbrand F; Gründig E; Binder H
    Wien Klin Wochenschr; 1978 Jan; 90(2):43-8. PubMed ID: 203124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanidine: a review.
    Sevka MJ
    Conn Med; 1979 Jul; 43(7):431-3. PubMed ID: 225123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of myopathies and spinal muscular atrophies (author's transl)].
    Jerusalem F
    Schweiz Rundsch Med Prax; 1978 Jan; 67(4):118-22. PubMed ID: 341113
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of enzyme and ion determinations in the CSF in some degenerative nervous and muscular diseases].
    Popoviciu L; Dulău E; Tăranu A; Palade C; Grecu F
    Stud Cercet Neurol; 1969; 14(5):345-54. PubMed ID: 5371263
    [No Abstract]   [Full Text] [Related]  

  • 6. Guanidine in amyotrophic lateral sclerosis.
    Norris FH
    N Engl J Med; 1973 Mar; 288(13):690-1. PubMed ID: 4687267
    [No Abstract]   [Full Text] [Related]  

  • 7. [Free amino acids in nervous and muscular tissues of a patient wiht amyotrophic lateral sclerosis (author's transl)].
    Yoshino Y; Koike H; Akai K
    Rinsho Shinkeigaku; 1978 Jan; 18(1):30-4. PubMed ID: 630763
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of myopathies with ribonucleotides].
    Grinio LP; Korabel'nikova NI; Shabanova ME; Medvedev MI; Islamova IB; Bobrova KF
    Sov Med; 1991; (8):91. PubMed ID: 1763382
    [No Abstract]   [Full Text] [Related]  

  • 9. [Muscular weakness and creatinine excretion (author's transl)].
    Weisner B; Frerk C; Bernhardt W
    Nervenarzt; 1979 Sep; 50(9):582-6. PubMed ID: 537668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination of a myopathy and involvement of the central and peripheral nervous system (author's transl)].
    Marescaux C; Rumbach L; Ramdane S; Galmiche J; Warter JM
    Rev Otoneuroophtalmol; 1982; 54(1):61-2. PubMed ID: 6287555
    [No Abstract]   [Full Text] [Related]  

  • 11. [The efficacy of guanidine hydrochloride in the treatment of Werdnig-Hoffmann disease (author's transl)].
    Steinböck H; Binder H; Gerstenbrand F; Pilz E; Maida E
    Wien Klin Wochenschr; 1977 Apr; 89(8):269-72. PubMed ID: 857433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
    Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
    Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amino acid determinations in the serum of patients with multiple sclerosis (author's transl)].
    Kisser W
    Wien Klin Wochenschr; 1974 Feb; 86(3):80-2. PubMed ID: 4439940
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application].
    Blin O; Desnuelle C; Guelton C; Aubrespy G; Ardissonne JP; Crevat A; Pouget J; Serratrice G
    Rev Neurol (Paris); 1991; 147(5):392-4. PubMed ID: 1677212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free amino acid levels in amyotrophic lateral sclerosis.
    Patten BM; Harati Y; Acosta L; Jung SS; Felmus MT
    Ann Neurol; 1978 Apr; 3(4):305-9. PubMed ID: 666270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL; Krieger C; Hansen S; Eisen A
    Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and CSF amino acid levels in ALS.
    Loeb C; Mainardi P; Besio G; Lunardi G; Cogliolo I; Pioli F
    Acta Neurol Scand; 1994 Sep; 90(3):223-4. PubMed ID: 7847066
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contribution to enzymatic study in liquor and serum of different amyotrophic entities (author's transl)].
    Nieto Vales JM; Rodríguez Navarro I
    Folia Clin Int (Barc); 1973 Feb; 23(2):86-109. PubMed ID: 4804725
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognosis in amyotrophic lateral sclerosis.
    Norris FH
    Trans Am Neurol Assoc; 1971; 96():290-1. PubMed ID: 5159112
    [No Abstract]   [Full Text] [Related]  

  • 20. [Free amino acid changes in rat brain after intracysternal injection of antimetabolites -- comparison to those in amyotrophic lateral sclerosis (author's transl)].
    Koike H
    Rinsho Shinkeigaku; 1981 Jul; 21(7):611-8. PubMed ID: 7307402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.